New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor.

about

How I treat hepatitis C virus infection in patients with hematologic malignancies.Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant.

P2860

Q40604797-E3F23C37-30CA-467D-8A79-6D1813CAC7FD Q40943696-981699A8-02A4-4E5B-87D9-DE5A3556A57D

P2860

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor.

Item

http://www.wikidata.org/entity/Q42947767

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@en

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@nl

type

Item

label

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@en

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@nl

prefLabel

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@en

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@nl

P1476

New nucleotide polymerase inhi ...... from a positive HCV-RNA donor.

@en

P2093

Catherine Cordonnier

http://www.w3.org/2001/XMLSchema#string

Christine Robin

http://www.w3.org/2001/XMLSchema#string

Christophe Hézode

http://www.w3.org/2001/XMLSchema#string

Eric Gautier

http://www.w3.org/2001/XMLSchema#string

Florence Beckerich

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Beaumont

http://www.w3.org/2001/XMLSchema#string

Sébastien Maury

http://www.w3.org/2001/XMLSchema#string

P2860

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.

Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.

Long-term outcome of hepatitis C infection after bone marrow transplantation

P304

2613-2614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-06-582122

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Hézode

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267101791

http://www.w3.org/2001/XMLSchema#string

P698

25323689

http://www.w3.org/2001/XMLSchema#string

P932

4199962

http://www.w3.org/2001/XMLSchema#string

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor.

about

P2860

P2860

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932